Cartesian Therapeutics, Inc. (RNAC) Deferred Tax Assets, Valuation Allowance USD 2015 - 2023

Historical data

Taxonomy & unit: us-gaap: USD
Description: Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary: Cartesian Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2015 to 2023.
Cartesian Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $124M, a 2.76% decline year-over-year.

Deferred Tax Assets, Valuation Allowance, Quarterly Data (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2023	$124M	-$3.52M	-2.76%	Dec 31, 2023	10-K	2024-03-07
Q4 2022	$128M	-$1.53M	-1.18%	Dec 31, 2022	10-K	2024-03-07
Q4 2021	$129M	+$22.4M	+20.9%	Dec 31, 2021	10-K	2023-03-02
Q4 2020	$107M	+$16.3M	+17.9%	Dec 31, 2020	10-K	2022-03-10
Q4 2019	$90.7M	+$167M		Dec 31, 2019	10-K	2021-03-12
Q4 2018	-$76.2M	-$134M	-232%	Dec 31, 2018	10-K	2020-03-12
Q4 2017	$57.6M	+$4.73M	+8.94%	Dec 31, 2017	10-K	2019-03-15
Q4 2016	$52.9M	+$14.4M	+37.4%	Dec 31, 2016	10-K	2018-03-15
Q4 2015	$38.5M			Dec 31, 2015	10-K	2017-03-28

* An asterisk sign (*) next to the value indicates that the value is likely invalid.